|
⚲
|
| Keyboard |
| MX Associates LLP
✚
|
|
|---|---|
| CIK # | 0001624453 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001624453] | |
| 4 | [0001624453] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| MX Associates LLP | |
| Xenon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-12-31 | Other | 117,456 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-12-31 | Other | 1,169,286 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-12-31 | Other | 85,119 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-12-31 | Other | 85,119 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-12-31 | Other | 17,680 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Series E Preferred Shares · derivative
|
2014-11-09 | Conversion | 1,474,660 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-11-09 | Conversion | 1,474,660 |